These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 28100092

  • 1. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R.
    Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
    [Abstract] [Full Text] [Related]

  • 2. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R, Hurwitz S, Tauhid S, Bakshi R.
    BMC Neurol; 2017 Sep 05; 17(1):172. PubMed ID: 28874119
    [Abstract] [Full Text] [Related]

  • 3. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM, Zurawski J, Chu R, Tie Y, Tauhid S, Quattrucci M, Healy BC, Bakshi R.
    J Neurol; 2024 Oct 05; 271(10):6935-6943. PubMed ID: 39240345
    [Abstract] [Full Text] [Related]

  • 4. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R, Kim G, Tauhid S, Khalid F, Healy BC, Bakshi R.
    PLoS One; 2018 Oct 05; 13(11):e0206939. PubMed ID: 30408094
    [Abstract] [Full Text] [Related]

  • 5. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
    Uddin MN, Lebel RM, Seres P, Blevins G, Wilman AH.
    Mult Scler; 2016 Aug 05; 22(9):1133-43. PubMed ID: 26503237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH.
    Mult Scler; 2016 Sep 05; 22(10):1327-36. PubMed ID: 26541795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.
    Brain; 2018 Jun 01; 141(6):1665-1677. PubMed ID: 29741648
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.
    Neurology; 2018 Apr 10; 90(15):e1324-e1332. PubMed ID: 29540589
    [Abstract] [Full Text] [Related]

  • 13. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Eur Radiol; 2021 Feb 10; 31(2):706-715. PubMed ID: 32851443
    [Abstract] [Full Text] [Related]

  • 14. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
    Xiang B, Brier MR, Kanthamneni M, Wen J, Snyder AZ, Yablonskiy DA, Cross AH.
    Mult Scler; 2022 Sep 10; 28(10):1515-1525. PubMed ID: 35196933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Impact of MRI T1 Hypointense Brain Lesions on Cerebral Deep Gray Matter Volume Measures in Multiple Sclerosis.
    Buyukturkoglu K, Mormina E, De Jager PL, Riley CS, Leavitt VM.
    J Neuroimaging; 2019 Jul 10; 29(4):458-462. PubMed ID: 30892794
    [Abstract] [Full Text] [Related]

  • 20. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar 10; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.